Article
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
OncoTargets and Therapy · 2018 · Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F
Key facts
| Title | CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer |
|---|---|
| First author | Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F |
| Journal | OncoTargets and Therapy |
| Published | Sep 6, 2018 |
| DOI | 10.2147/OTT.S174329 |
| Devices mentioned | K103302 |
| Product codes mentioned | KIT, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1